Clinical trials
Terminated Phase 1 trials in Sweden
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
37 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 2 |
| 2008 | 1 |
| 2009 | 4 |
| 2010 | 1 |
| 2011 | 1 |
| 2013 | 3 |
| 2014 | 1 |
| 2015 | 2 |
| 2017 | 1 |
| 2018 | 8 |
| 2019 | 2 |
| 2020 | 3 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 37 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 5 |
| H. Lundbeck A/S | 4 |
| Adaptimmune | 3 |
| Bristol-Myers Squibb | 2 |
| Celgene | 2 |
| GlaxoSmithKline | 2 |
| Incyte Corporation | 2 |
| Novartis Pharmaceuticals | 2 |
| Boehringer Ingelheim | 1 |
| Hoffmann-La Roche | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alzheimer Disease | 3 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Liposarcoma, Myxoid | 3 |
| Neoplasms | 3 |
| Amyloidosis | 2 |
| Diabetes Mellitus, Type 2 | 2 |
| Endometrial Neoplasms | 2 |
| Glioblastoma | 2 |
| Melanoma | 2 |
| Neoplasm Metastasis | 2 |
Trials
Showing 1 to 25 of 37. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.